APA (7th ed.) Citation

EA, R., MP, J., K, R., IL, v. S., MP, L., ME, v. G., . . . EM, B. (2011). Decreased expression of EZH2 is associated with upregulation of ER and favorable outcome to tamoxifen in advanced breast cancer. Breast cancer research and treatment, 125(2), 387. https://doi.org/10.1007/s10549-010-0836-9

Chicago Style (17th ed.) Citation

EA, Reijm, et al. "Decreased Expression of EZH2 Is Associated with Upregulation of ER and Favorable Outcome to Tamoxifen in Advanced Breast Cancer." Breast Cancer Research and Treatment 125, no. 2 (2011): 387. https://doi.org/10.1007/s10549-010-0836-9.

MLA (9th ed.) Citation

EA, Reijm, et al. "Decreased Expression of EZH2 Is Associated with Upregulation of ER and Favorable Outcome to Tamoxifen in Advanced Breast Cancer." Breast Cancer Research and Treatment, vol. 125, no. 2, 2011, p. 387, https://doi.org/10.1007/s10549-010-0836-9.